Salem Investment Counselors’s Amgen AMGN Stock Holding History

Salem Investment Counselors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9M	Buy	32,937 +2,228	+7%	+$763K	0.3%	49
2026 Q1	$10.8M	Buy	30,709 +775	+3%	+$276K	0.32%	52
2025 Q4	$9.8M	Buy	29,934 +1,016	+4%	+$322K	0.28%	53
2025 Q3	$8.16M	Buy	28,918 +1,558	+6%	+$452K	0.23%	64
2025 Q2	$7.64M	Buy	27,360 +1,016	+4%	+$288K	0.24%	64
2025 Q1	$8.21M	Buy	26,344 +678	+3%	+$200K	0.29%	58
2024 Q4	$6.69M	Buy	25,666 +1,395	+6%	+$414K	0.22%	66
2024 Q3	$7.82M	Buy	24,271 +682	+3%	+$223K	0.24%	63
2024 Q2	$7.37M	Buy	23,589 +1,077	+5%	+$316K	0.24%	63
2024 Q1	$6.4M	Buy	22,512 +3,423	+18%	+$1M	0.21%	73
2023 Q4	$5.5M	Buy	19,089 +1,012	+6%	+$276K	0.19%	77
2023 Q3	$4.86M	Buy	18,077 +16,915	+1,456%	+$4.22M	0.19%	82
2023 Q2	$258K	Buy	1,162 +148	+15%	+$34.3K	0.01%	302
2023 Q1	$245K	Buy	1,014 +17	+2%	+$4.17K	0.01%	316
2022 Q4	$262K	Hold	997	–	–	0.01%	301
2022 Q3	$225K	Sell	997 -38	-4%	-$9.21K	0.01%	292
2022 Q2	$252K	Buy	1,035 +45	+5%	+$11K	0.01%	301
2022 Q1	$239K	Sell	990 -676	-41%	-$155K	0.01%	318
2021 Q4	$375K	Buy	1,666 +20	+1%	+$4.22K	0.01%	301
2021 Q3	$350K	Sell	1,646 -73	-4%	-$16.8K	0.02%	284
2021 Q2	$419K	Buy	1,719 +793	+86%	+$195K	0.02%	255
2021 Q1	$230K	Buy	926 +101	+12%	+$24.1K	0.01%	272
2020 Q4	$190K	Buy	825 +167	+25%	+$38.5K	0.01%	281
2020 Q3	$167K	Hold	658	–	–	0.01%	257
2020 Q2	$155K	Buy	658 +8	+1%	+$1.82K	0.01%	261
2020 Q1	$132K	Buy	650 +50	+8%	+$10.9K	0.01%	261
2019 Q4	$145K	Hold	600	–	–	0.01%	265
2019 Q3	$116K	Sell	600 -70	-10%	-$13.4K	0.01%	287
2019 Q2	$123K	Sell	670 -173	-21%	-$31K	0.01%	280
2019 Q1	$175K	Buy	+843	New	+$161K	0.02%	197
2018 Q4	–	Sell	-843	Closed	-$175K	–	192
2018 Q3	$175K	Hold	843	–	–	0.02%	197
2018 Q2	$156K	Hold	843	–	–	0.01%	207
2018 Q1	$141K	Hold	843	–	–	0.02%	211
2017 Q4	$147K	Hold	843	–	–	0.02%	214
2017 Q3	$157K	Buy	843 +34	+4%	+$6.02K	0.02%	207
2017 Q2	$139K	Buy	809 +36	+5%	+$5.86K	0.02%	222
2017 Q1	$127K	Hold	773	–	–	0.01%	273
2016 Q4	$113K	Hold	773	–	–	0.01%	279
2016 Q3	$1.29K	Buy	+773	New	+$131K	0.02%	242

Other funds holding AMGN

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFM

Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

SMDAM

Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return

Salem Investment Counselors's AMGN Position: Q2 2026 in Review

Salem Investment Counselors increased its Amgen (AMGN) stake by 7.3% in Q2 2026, buying an estimated $763K and bringing the position to 32,937 shares worth $11.9M. The position accounts for 0.3% of the portfolio, ranked #49.

Salem Investment Counselors first reported a position in AMGN in Q3 2016 and has held it in 39 quarters since. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Salem Investment Counselors held 32,937 shares of Amgen worth $11.9M as of Q2 2026.
Salem Investment Counselors bought 2,228 Amgen shares in Q2 2026, an estimated $763K.
Amgen made up 0.3% of Salem Investment Counselors's portfolio in Q2 2026, its #49 holding.
Salem Investment Counselors first reported a position in Amgen in Q3 2016 and has held it in 39 quarters since.
1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.